Monogram Orthopaedics (NASDAQ:MGRM – Get Free Report) and United American Healthcare (OTCMKTS:UAHC – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, valuation, profitability, analyst recommendations, risk, dividends and earnings.
Valuation & Earnings
This table compares Monogram Orthopaedics and United American Healthcare”s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Monogram Orthopaedics | $364,999.00 | 225.61 | -$13.74 million | ($0.47) | -5.11 |
United American Healthcare | N/A | N/A | $720,000.00 | N/A | N/A |
United American Healthcare has lower revenue, but higher earnings than Monogram Orthopaedics.
Profitability
Net Margins | Return on Equity | Return on Assets | |
Monogram Orthopaedics | N/A | -130.90% | -106.38% |
United American Healthcare | N/A | N/A | N/A |
Insider and Institutional Ownership
0.4% of Monogram Orthopaedics shares are owned by institutional investors. 28.1% of Monogram Orthopaedics shares are owned by insiders. Comparatively, 14.3% of United American Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Analyst Ratings
This is a summary of current ratings for Monogram Orthopaedics and United American Healthcare, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Monogram Orthopaedics | 0 | 0 | 1 | 1 | 3.50 |
United American Healthcare | 0 | 0 | 0 | 0 | 0.00 |
Monogram Orthopaedics presently has a consensus price target of $4.00, indicating a potential upside of 66.67%. Given Monogram Orthopaedics’ stronger consensus rating and higher possible upside, equities research analysts plainly believe Monogram Orthopaedics is more favorable than United American Healthcare.
Volatility & Risk
Monogram Orthopaedics has a beta of 1.51, indicating that its stock price is 51% more volatile than the S&P 500. Comparatively, United American Healthcare has a beta of -1.34, indicating that its stock price is 234% less volatile than the S&P 500.
Summary
Monogram Orthopaedics beats United American Healthcare on 8 of the 11 factors compared between the two stocks.
About Monogram Orthopaedics
Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.
About United American Healthcare
United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.
Receive News & Ratings for Monogram Orthopaedics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monogram Orthopaedics and related companies with MarketBeat.com's FREE daily email newsletter.